Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹5,967 Cr₹5,819 Cr₹4,546 Cr₹4,689 Cr₹4,201 Cr

What is the latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹5,967 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹5,967 Cr
Mar2024₹5,819 Cr
Mar2023₹4,546 Cr
Mar2022₹4,689 Cr
Mar2021₹4,201 Cr

How is Total Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2025 ₹5,967 Cr
2.55
Mar2024 ₹5,819 Cr
27.99
Mar2023 ₹4,546 Cr
-3.05
Mar2022 ₹4,689 Cr
11.63
Mar2021 ₹4,201 Cr -

Compare Total Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,789.1 Cr 1.5% -8.4% 31.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,104.0 Cr 3.5% -1.5% 9% Stock Analytics
DIVIS LABORATORIES ₹180,119.0 Cr 1.1% -1.1% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,871.0 Cr -0.2% -0.3% 35% Stock Analytics
CIPLA ₹114,334.0 Cr 3.1% 1% -11.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,761.0 Cr 1.1% -2.1% -5.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.5%

-8.4%

31.6%

SENSEX

1.1%

2.4%

-5%


You may also like the below Video Courses